IL5 and cancer: Figure 6A shows such a comparison for 21 gene sets across 9 different cancer types. The figure suggests that pathways such as cell cycle and apoptosis are more commonly dysregulated across multiple cancer types, while the dysregulation of other pathways such as IL5 is cancer type specific. Similarly, Figure 6B reveals pathways that have survival correlations only in specific cancer types, such as the cell cycle pathway in breast cancer but not non-small cell lung cancer [41].